PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA.

Detalles Bibliográficos
Autores principales: Yosra Kanoun, Rimmel, Ben Adejlil, Nour, Rabeb, Jaied, Hsasna, Roua, Siwar, Frigui, Mekni, Sabrine, Torjemane, Lamia, Turki, Ines, Belloumi, Dorra, Rihab, Ouerghi, Yaiche, Insaf Ben, Wafa, Achour, Saloua, Ladeb, Ben Othman, Tarek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429059/
http://dx.doi.org/10.1097/01.HS9.0000976404.38888.d8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429059/
http://dx.doi.org/10.1097/01.HS9.0000976404.38888.d8

Ejemplares similares